Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

New Developments in Vision Research April 2019

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

PDF

Ann-Margret Ervin; Rupert W. Strauss; Mohamed I. Ahmed; David Birch; Janet Cheetham; Frederick L. Ferris III; Michael S. Ip; Glenn J. Jaffe; Maureen G. Maguire; Etienne M. Schönbach; SriniVas R. Sadda; Sheila K. West; Hendrik P.N. Scholl; for the ProgStar Study Group
TAGS: atrophy, prospective studies, eye, stargardt's disease, spectral-domain optical coherence tomography
Trans. Vis. Sci. Tech.. 2019; 8(2):16. doi: 10.1167/tvst.8.2.16

ARVO Annual Meeting Abstract July 2018

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Katherine Grace Chen; Jason Alvarez; Wai T Wong; Henry Wiley; Emily Y. Chew; Frederick L Ferris; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2423. doi:

ARVO Annual Meeting Abstract July 2018

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Tiarnan D L Keenan; Elvira Agron; Amitha Domalpally; Traci E Clemons; Freekje Van Asten; Wai T Wong; Ronald P Danis; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6010. doi:

ARVO Annual Meeting Abstract July 2018

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Panos George Christakis; Elvira Agron; Michael L Klein; J. Peter Campbell; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4947. doi:

Articles February 2017

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

PDF

Alex S. Willoughby; Stephanie J. Chiu; Rachel K. Silverman; Sina Farsiu; Clare Bailey; Henry E. Wiley; Frederick L. Ferris, III; Glenn J. Jaffe
TAGS: software, eye, macular edema, diabetic
Trans. Vis. Sci. Tech.. 2017; 6(1):9. doi: 10.1167/tvst.6.1.9

Research Opportunities October 2016

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop

PDF

Prashant Nair; Lloyd Paul Aiello; Thomas W. Gardner; Lee M. Jampol; Frederick L. Ferris III
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, united states food and drug administration, vision, visual acuity, eye, surrogate endpoints, anti-vascular endothelial growth factor therapy
Invest. Ophthalmol. Vis. Sci.. 2016; 57(13):5127-5142. doi: 10.1167/iovs.16-20356

ARVO Annual Meeting Abstract September 2016

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Ebenezer Daniel; Juan E Grunwald; Benjamin J Kim; Maureen G Maguire; James A Shaffer; Glenn J Jaffe; Cynthia A Toth; Daniel F Martin; Frederick L Ferris; Gui-Shuang Ying

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2653. doi:

ARVO Annual Meeting Abstract September 2016

Clinical characterization of Ebola-associated eye disease with spectral domain optical coherence tomography

Allen O Eghrari; Rachel Jessica Bishop; Christopher J. Brady; Vincent Ray; Mosoka Fallah; Denise Cunningham; Cavan S Reilly; Frederick L Ferris; Jemma Larbelee

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1668. doi:

ARVO Annual Meeting Abstract September 2016

Implementation and assessment of visual acuity screening of Ebola Virus Disease survivors utilizing the Peek Vision smartphone platform

Sina Vahedi; Allen O Eghrari; Rachel Jessica Bishop; Christopher J. Brady; Cavan S Reilly; Frederick L Ferris; Jemma Larbelee; Mosoka Fallah

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5537. doi:

ARVO Annual Meeting Abstract June 2015

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Henry Wiley; Clare Bailey; Catherine A Cukras; Glenn J Jaffe; Richard W J Lee; Erin Loken; Catherine Meyerle; Darby J.S. Thompson; Wai T Wong; Frederick L Ferris

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3149. doi:

ARVO Annual Meeting Abstract June 2015

Evaluating the AREDS grading scale for age-related macular degeneration in AREDS2

Susan Vitale; Traci E Clemons; Elvira Agron; Frederick L Ferris; Amitha Domalpally; Ronald P Danis; Emily Y Chew; AREDS2 Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3794. doi:

ARVO Annual Meeting Abstract June 2015

Comparing retinal sensitivity and SDOCT volumes in the AMD Phenotype and Genotype study

Vincent Tai; Monica Bernadette Sevilla; Traci E Clemons; Emily Y Chew; Frederick L Ferris; Sina Farsiu; Cynthia A Toth

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5154. doi:

Clinical Trials January 2015

Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial

PDF

Philip A. Petrou; Denise Cunningham; Katherine Shimel; Molly Harrington; Keri Hammel; Catherine A. Cukras; Frederick L. Ferris; Emily Y. Chew; Wai T. Wong
TAGS: rapamycin, atrophy, visual acuity, eye
Invest. Ophthalmol. Vis. Sci.. 2015; 56(1):330-338. doi: 10.1167/iovs.14-15877

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Changes in Occurrence of Anti-Retinal Autoantibodies Associated with the Progression from “Dry” To “Wet” AMD

Grazyna Adamus; Emily Y Chew; Frederick L Ferris; Michael L Klein

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):78. doi:

ARVO Annual Meeting Abstract April 2014

Effect of Aspirin Use on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2 (AREDS2) Participants

Mary E Aronow; Michael L Klein; Traci E Clemons; Frederick L Ferris; Elvira Agron; Barbara A Blodi; Emily Y Chew; The AREDS2 Rearch Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2993. doi:

ARVO Annual Meeting Abstract April 2014

Area Measurement of the Ellipsoid Zone (EZ) by SD-OCT and its Correlation with Visual Field Identifies a Potential Anatomical Endpoint for Clinical Trials in Retinitis Pigmentosa (RP)

Alexander Ho; Travis Smith; Amirhossein Hariri; Elvira Chegarnov; Frederick L Ferris; Paul Van Veldhuisen; Srinivas R Sadda; Richard G Weleber; David G Birch; VPA Clinical Trial Group, EZ Area Working Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3380. doi:

ARVO Annual Meeting Abstract April 2014

Candidate serum protein biomarkers of age-related macular degeneration (AMD)

Tammy M Martin; Michael L Klein; Phillip A Wilmarth; Frederick L Ferris; Emily Y Chew; Ashok P Reddy; Larry L David

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):574. doi:

ARVO Annual Meeting Abstract April 2014

Intravitreal Sirolimus for the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration: Results of a Phase I/II Trial

Philip A Petrou; Katherine Shimel; Catherine A Cukras; Frederick L Ferris; Emily Y Chew; Wai T Wong

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5892. doi:

ARVO Annual Meeting Abstract April 2014

Rates of Vision Loss in Patients with Geographic Atrophy in AREDS and AREDS 2

David Valent; Emily Y Chew; Elvira Agron; Frederick L Ferris; Philip J Rosenfeld; Traci E Clemons; Wai T Wong; Age Related Eye Disease Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5894. doi:

ARVO Annual Meeting Abstract April 2014

Impairment in Dark Adaptation is Associated with Age-Related Macular Degeneration Severity and Reticular Drusen

Jason Flamendorf; Elvira Agron; Shaza Al-Holou; Henry Wiley; Wai T Wong; Emily Y Chew; Frederick L Ferris; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5221. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software

Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop

Hard Exudates and Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Clinical characterization of Ebola-associated eye disease with spectral domain optical coherence tomography

Implementation and assessment of visual acuity screening of Ebola Virus Disease survivors utilizing the Peek Vision smartphone platform

A randomized 36-week crossover trial comparing ranibizumab and bevacizumab for diabetic macular edema

Evaluating the AREDS grading scale for age-related macular degeneration in AREDS2

Comparing retinal sensitivity and SDOCT volumes in the AMD Phenotype and Genotype study

Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial

Changes in Occurrence of Anti-Retinal Autoantibodies Associated with the Progression from “Dry” To “Wet” AMD

Effect of Aspirin Use on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2 (AREDS2) Participants

Area Measurement of the Ellipsoid Zone (EZ) by SD-OCT and its Correlation with Visual Field Identifies a Potential Anatomical Endpoint for Clinical Trials in Retinitis Pigmentosa (RP)

Candidate serum protein biomarkers of age-related macular degeneration (AMD)

Intravitreal Sirolimus for the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration: Results of a Phase I/II Trial

Rates of Vision Loss in Patients with Geographic Atrophy in AREDS and AREDS 2

Impairment in Dark Adaptation is Associated with Age-Related Macular Degeneration Severity and Reticular Drusen

To View More...

You must be signed into an individual account to use this feature.